Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Beverley Mavis Kerr"'
Autor:
Beverley Mavis Kerr, Catherine M. Lanagan, Suzanne L. Elliott, Christopher W. Schmidt, John R. Bell, Beth Crowe, Greg J. Slater, Kay A.O. Ellem, David M. Purdie, Michael G. E. O'Rourke, Janet L. See, Maree K. Johnson, Jie Yang
Publikováno v:
Cancer immunology, immunotherapy : CII. 52(6)
Advanced metastatic melanoma is incurable by standard treatments, but occasionally responds to immunotherapy. Recent trials using dendritic cells (DC) as a cellular adjuvant have concentrated on defined peptides as the source of antigens, and rely on
Autor:
Sharon L. Silins, Simone M. Cross, Beverley Mavis Kerr, Norbert Kienzle, B Coupar, Denis J. Moss, T. B. Sculley, Marion Buck, E M Benson, Jacqueline M. Burrows
Publikováno v:
Europe PubMed Central
Persistent Epstein-Barr virus (EBV) infection is primarily controlled by HLA class I-restricted memory cytotoxic T-cell (CTL) responses which can be reactivated in vitro by stimulation of peripheral blood lymphocytes with autologous lymphoblastoid ce
Autor:
I. S. Misko, Beverley Mavis Kerr, Michael G. Kurilla, Denis J. Moss, Catherine A. White, Rajiv Khanna, Christopher W. Schmidt, Simone M. Cross
Publikováno v:
Virology. (2):489-492
Epstein–Barr virus (EBV) is the aetiological agent of infectious mononucleosis (IM) which is a common sequel to primary EBV infection. Thereafter, the virus is maintained as a lifetime latent infection. Although the proteins expressed during the la